pf-04531083
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2009 (NCT01012310)
Timeline
Indications
Mechanism of action
SCN10A blocker
Chemistry & pharmacology
Loading structure…
SMILES
COc1ccc(Cl)c(-c2ccc(NC(=O)c3ccnn3C)nc2N)c1- Mol. weight
- 357.8 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3589904 ↗
- ChEMBLCHEMBL3544951 ↗
Also known as
- pf-04531083
- pf-04531083
- pf-04531083
- pf-04531083
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01512160 | Phase 2 | Oct 1, 2011 | Pfizer |
| NCT01127906 | Phase 1 | Jun 1, 2010 | Pfizer |
| NCT01119235 | Phase 1 | May 1, 2010 | Pfizer |
| NCT01103739 | Phase 1 | Mar 1, 2010 | Pfizer |
| NCT01012310 | Phase 1 | Nov 1, 2009 | Pfizer |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 5 | 5 | 2 | 2009 |
1 organizations
Page 1 / 1